U.S. Physical Therapy, Inc. (NYSE:USPH) CEO Sells $81,369.39 in Stock

Share on StockTwits

U.S. Physical Therapy, Inc. (NYSE:USPH) CEO Christopher J. Reading sold 601 shares of the stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $135.39, for a total transaction of $81,369.39. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Christopher J. Reading also recently made the following trade(s):

  • On Monday, August 19th, Christopher J. Reading sold 7,000 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $135.13, for a total transaction of $945,910.00.
  • On Tuesday, May 21st, Christopher J. Reading sold 19,860 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $119.36, for a total transaction of $2,370,489.60.

Shares of USPH stock opened at $135.11 on Thursday. The firm has a 50-day moving average of $128.52 and a 200-day moving average of $116.52. The company has a market cap of $1.72 billion, a P/E ratio of 47.80, a P/E/G ratio of 3.74 and a beta of 1.13. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.88 and a quick ratio of 1.88. U.S. Physical Therapy, Inc. has a one year low of $98.69 and a one year high of $137.15.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, August 8th. The company reported $0.81 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.81. The company had revenue of $126.40 million during the quarter, compared to the consensus estimate of $124.86 million. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.19%. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.73 earnings per share. As a group, research analysts expect that U.S. Physical Therapy, Inc. will post 2.94 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Thursday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Wednesday, August 14th. This represents a $1.20 annualized dividend and a yield of 0.89%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.27. U.S. Physical Therapy’s dividend payout ratio is presently 45.28%.

Several analysts have recently commented on the stock. Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, May 3rd. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $113.54.

Institutional investors and hedge funds have recently bought and sold shares of the stock. TCG Advisors LP bought a new position in U.S. Physical Therapy during the first quarter valued at about $25,000. NumerixS Investment Technologies Inc bought a new position in U.S. Physical Therapy during the second quarter valued at about $61,000. Quadrant Capital Group LLC grew its position in U.S. Physical Therapy by 1,729.4% during the first quarter. Quadrant Capital Group LLC now owns 622 shares of the company’s stock valued at $63,000 after buying an additional 588 shares during the period. Ladenburg Thalmann Financial Services Inc. grew its position in U.S. Physical Therapy by 74.0% during the second quarter. Ladenburg Thalmann Financial Services Inc. now owns 548 shares of the company’s stock valued at $67,000 after buying an additional 233 shares during the period. Finally, Tower Research Capital LLC TRC bought a new position in U.S. Physical Therapy during the second quarter valued at about $91,000. Institutional investors own 99.58% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Story: Rule of 72

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.